US equities
|
MU
$1,057.10
▲+1.10%
NVDA
$238.00
▼-0.52%
SNDK
$1,698.15
▲+2.27%
AMD
$638.84
▼-1.63%
INTC
$115.01
▲+2.23%
SPCX
$168.68
▼-1.88%
TSLA
$375.45
▼-1.37%
MRVL
$284.73
▼-0.79%
MU
$1,057.10
▲+1.10%
NVDA
$238.00
▼-0.52%
SNDK
$1,698.15
▲+2.27%
AMD
$638.84
▼-1.63%
INTC
$115.01
▲+2.23%
SPCX
$168.68
▼-1.88%
TSLA
$375.45
▼-1.37%
MRVL
$284.73
▼-0.79%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about OTCB:SKYE
Recent news which mentions OTCB:SKYE
Skye Bioscience moving ahead with SBI-100 clinical trial after positive safety review
February 24, 2023
Tags
OTCB:SKYE
Skye Bioscience Inc
From
TheNewswire.com - RSS (Media)